Orforglipron

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status 
Orforglipron 2212020-52-3 Dec, 2026  Sep.26, 2037 estimated PV Completion – Sep, 2026

[Product]   

Provide the API as well as the SDD (Spray Dried Dispersion)

[Indication]

1. Type 2 diabetes mellitus:To improve glycemic control in adults with type 2 diabetes mellitus.

2. For clinical research, now it can be used for Chronic weight management in adults.


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us